background

Small Molecules (NCEs & Complex Generics)

Integrated Small Molecule Oversight: Discovery to Commercial Launch

Small Molecules (NCEs & Complex Generics)

Bridging the gap between lab-scale discovery and GMP reality. Independent technical governance across the full small-molecule lifecycle—from target validation and medicinal chemistry through process development, tech transfer, GMP manufacturing, and commercial supply.

    Key Risks We Govern

  • Tech-transfer knowledge loss and batch-to-batch inconsistency

  • Data-integrity and documentation shortfalls that delay IND or marketing applications

  • Integrated IDDD Model:
    A single point of coordination for your entire development lifecycle.

  • Independent Governance:
    Unbiased partner vetting and "Person-in-Plant" oversight to protect your IP and data.

  • Regulatory Certainty:
    Ensuring every milestone-from MedChem to CMC-is USFDA/EMA submission-ready.

about

 

Technical Capability Matrix

Our vetted partner network supports complex synthetic transformations and challenging chemistries.

Discovery Chemistry & Medicinal Chemistry Advisory

"Leverage deep Indian expertise in hit identification and lead optimization at a 40–60% cost advantage."

  • The Aventiq Edge: Early-stage route scouting conducted during discovery to identify and eliminate downstream scalability bottlenecks.

Why choose Aventiq Bio for small molecules

Independent, vendor-neutral oversight with deep process-chemistry and solid-state expertise. We protect your route IP, enforce impurity and form control standards, and keep every data package submission-ready—without owning any laboratory or accepting vendor commissions.

All engagements are confidential. No information is shared without written consent.
×

Search

Press Enter to search